Pressmeddelanden

17 april, 2024 Regulatoriskt

AcuCort publishes the annual report for 2023

11 mars, 2024 Regulatoriskt

Insider trading in subscription option TO1 - CEO Jonas Jönmark increases his stake in AcuCort AB

27 februari, 2024 Regulatoriskt

AcuCort receives its first order of Zeqmelit®

31 januari, 2024 Regulatoriskt

First patient using Zeqmelit® in study ahead of market launch